ALX Oncology Holdings Inc. Share Price
NASDAQ: ALXO | Micro CapALX Oncology Holdings Inc. Stock Performance
ALX Oncology Holdings Inc. Share Price Today
As of 31 October 2026, ALX Oncology Holdings Inc.'s share price is $1.22. The stock opened at $1.20, compared to its previous close of $1.23. During today's trading session, ALX Oncology Holdings Inc.'s share price traded between $1.20 and $1.26, with an average price of $1.23. Over the past 52 weeks, the stock has recorded a high of $2.66 and a low of $0.87. In terms of performance, ALX Oncology Holdings Inc.'s share price has declined by 28.24% over the last six months and is down 21.04% on a year-on-year basis.
ALX Oncology Holdings Inc. Share Price Chart
ALX Oncology Holdings Inc. Quarterly Profit & Loss
All figures in USD
ALX Oncology Holdings Inc. Annual Profit & Loss
All figures in USD
About ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
ALX Oncology Holdings Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.38 | $1.23 | -12.19% |
Sep 2026 | $1.94 | $1.40 | -31.95% |
Aug 2026 | $1.99 | $2.05 | +5.40% |
Jul 2026 | $2.04 | $1.95 | -6.04% |
Jun 2026 | $1.86 | $2.07 | +7.81% |
May 2026 | $1.75 | $1.92 | +12.94% |
Apr 2026 | $2.05 | $1.70 | -15.21% |
Mar 2026 | $2.09 | $2.00 | -5.42% |
Feb 2026 | $1.66 | $2.12 | +21.49% |
Jan 2026 | $1.12 | $1.75 | +53.74% |
Dec 2025 | $1.38 | $1.14 | -16.85% |
Nov 2025 | $1.62 | $1.36 | -11.65% |